Karen Sanders Selected Research

Hearing Loss (Hearing Impairment)

11/2022

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen Sanders Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 07/2015 - 02/2009
3	Tuberculosis (Tuberculoses) 11/2022 - 01/2019
2	Neoplasms (Cancer) 07/2015 - 02/2009
2	Neoplasm Metastasis (Metastasis) 05/2012 - 09/2009
1	HIV Infections (HIV Infection) 03/2024
1	Hearing Loss (Hearing Impairment) 11/2022
1	Latent Tuberculosis 01/2022
1	Pathologic Processes 07/2017
1	Disease Progression 05/2012
1	Heart Arrest (Cardiac Arrest) 02/2011
1	Cardiogenic Shock 02/2011

Drug/Important Bio-Agent (IBA)

5	Hormones (Hormone)IBA 09/2012 - 02/2009
3	Rifampin (Rifampicin)FDA LinkGeneric 11/2022 - 01/2019
2	AminoglycosidesIBA 11/2022 - 01/2019
2	FluoroquinolonesIBA 11/2022 - 01/2019
2	AndrogensIBA 07/2015 - 12/2011
2	Prostate-Specific Antigen (Semenogelase)IBA 05/2012 - 12/2011
2	Celecoxib (Celebrex)FDA Link 05/2012 - 02/2009
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2024
1	bedaquiline (R207910)IBA 11/2022
1	rifapentine (Priftin)FDA Link 01/2022
1	ProteomeIBA 07/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 02/2011
1	Clodronic Acid (Clodronate)IBA 09/2009
1	Diphosphonates (Bisphosphonates)IBA 09/2009
1	Zoledronic Acid (Zometa)FDA Link 02/2009
1	Docetaxel (Taxotere)FDA Link 02/2009

Therapy/Procedure

6	Therapeutics 07/2015 - 02/2009
3	Radiotherapy 07/2015 - 12/2011
1	Aftercare (After-Treatment) 03/2024
1	Injections 11/2022
1	Electric Countershock (Cardioversion) 02/2011
1	Resuscitation 02/2011